New Treatment Approaches for Leukemias Emerging From Early Clinical Trials
New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy
Genasense Added To Chemo Improves Responses in CLL
Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen
Of Smokers Screened With CT In Study, 7% Have Lung Cancer
Insulin For Diabetes Increases Risk Of Colorectal Cancer
NCI-Approved Clinical Trials
Trending Stories
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - “Page Not Found:” HHS agencies purge web pages that hint at DEI, health equity, and gender
Medical group sues over removing “information used every day by health professions” - 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- Preparing to take care of each other in ways we never imagined